N-{2-[(Triphenylmethyl)sulfanyl]ethyl}prop-2-enamide | 402483-79-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 三苯基化合物
• 英文名称: N-{2-[(Triphenylmethyl)sulfanyl]ethyl}prop-2-enamide
• 英文别名: N-(2-tritylsulfanylethyl)prop-2-enamide
• CAS: 402483-79-8
• 化学式: C₂₄H₂₃NOS
• 分子量: 373.5
• InChiKey: ZUAJXCBARBRTLA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.5
• 重原子数：
  27
• 可旋转键数：
  8
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  54.4
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• Novel polymer compounds
  申请人：——

  公开号：US20020177680A1

  公开（公告）日：2002-11-28

  Provided is a composition comprising a pre-formed, hydrolytically susceptible non-addition polyanionic polymer comprising polymer strands formed from at least one ethylenically unsaturated monomer and linking the polymer strands by at least one linking moiety comprising a hydrolytically susceptible bond, wherein at least one of which monomers has: i) one or more functional groups that can be titrated with base to form negatively charged functional groups; or ii) one or more precursor groups that are precursors of the functional groups that can be titrated with base; which precursor groups are converted to the functional groups.

  提供了一种组合物，该组合物包含一种预成型的、易水解的非加成聚阴离子聚合物，该聚合物包含由至少一种乙烯基不饱和单体形成的聚合物链，并通过至少一种包含易水解键的连接分子将聚合物链连接起来，其中至少一种单体具有以下特征：i) 一个或多个可与碱滴定以形成带负电荷官能团的官能团；或 ii) 一个或多个可与碱滴定的官能团的前体基团；这些前体基团可转化为官能团。
• NOVEL POLYMER COMPOUNDS
  申请人：Phairson Medical, Inc.

  公开号：EP1320553A1

  公开（公告）日：2003-06-25
• EP1320553A4
  申请人：——

  公开号：EP1320553A4

  公开（公告）日：2006-03-15
• US6943211B1
  申请人：——

  公开号：US6943211B1

  公开（公告）日：2005-09-13
• [EN] NOVEL POLYMER COMPOUNDS<br/>[FR] NOUVEAUX COMPOSES POLYMERES
  申请人：PHAIRSON MEDICAL INC

  公开号：WO2002016443A1

  公开（公告）日：2002-02-28

  Provided is a composition comprising a pre-formed, hydrolytically susceptible non-addition polyanionic polymer comprising polymer strands formed from at least one ethylenically unsaturated monomer and linking the polymer strands by at least one linking moiety comprising a hydrolytically susceptible bond, wherein at least one of which monomers has: i) one or more functional groups that can be titrated with base to form negatively charged functional groups: or ii) one or more precursor groups that are precursors of the functional groups that can be titrated with base; which precursor groups are converted to the functional groups.